Clinical Trial Update: Study of Keto Acid (KA) on Insulin Resistance in Peritoneal Dialysis (PD) Patients [Phase 3]

View source ↗

Summary

Phase 3 study evaluating Keto Acid (KA) for insulin resistance in peritoneal dialysis patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance

Drugs mentioned

• Keto Acid (KA) (Keto Acid)

Snippet

Sponsor: Peking University First Hospital | Conditions: Insulin Resistance | Phase 3 | Status: COMPLETED